BSECompany Update2d ago · 10 Nov 2026, 11:04 am
Monitoring Agency Report for the Quarter ended September 30, 2026
Paramount Communications Ltd-$ · 530555
✦ AI SummaryResults
Paramount Communications Ltd has received a Monitoring Agency Report for the quarter ended September 30, 2026, from CARE Ratings Limited, which confirms that the company has utilized the proceeds from its Preferential issue of Equity shares and Fully Convertible warrants in accordance with the objects of the issue.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Paramount Communications Ltd-$ - 530555 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Attachments (1)
📄pdf
Download →
58e9706c-9b04-4293-9aae-cf1ccee3dfbb.pdf
View document text
(R PARAMOUNT
WIRES & CABLES
Date:10.11.2026
The Department of Corporate Services Listing Department
BSE Limited National Stock Exchange of India Ltd.
Phiroze Jeejeebhoy Towers, C-1, G-Block, Bandra-Kurla Complex,
Dalal Street, Mumbai, MH-400001 Bandra (East), Mumbai, MH-400051
Svmbol/Scrip Code: (BSE)530555/(NSE) PARACABLES
Subject: Monitoring Agency Report for the quarter ended September 30, 2026
Dear Sir / Madam,
Pursuant to the Regulation 32(6) of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 162A of
the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements)
Regulations, 2018, enclosed herewith is the Monitoring Agency Report for the quarter ended
September 30, 2026 issued by CARE Ratings Limited, Monitoring Agency for the utilization
of the proceeds raised through Preferential issue of Equity Shares and unlisted convertible
‘warrants.
The aforesaid information is also being made available on the website of the Company at
https://paramountcables.com/
This is for your information and record.
Yours sincerely,
For Paramount Communications Limited
Rashi Goel
Company Secretary & Compliance Officer
FCS 9577
Paramount Communications Ltd
Paramount House
KH - 433, Maulsari Avenue,
Westend Greens, Rangpuri,
New Delhi - 110037, India
t: 491 1145618800
pel@paramountcables.com
www.paramountcables.com
CIN: L74899DL1994PLCO61295
No. CARE/NRO/GEN/2026-27/1165
The Board of Directors
Paramount Communications Limited
KH-433, Maulsari Avenue,
Westend Greens, Rangpuri
New Delhi 110037
November 06, 2026
Dear Sir/Ma’am,
Monitoring Agency Report for the quarter ended September 30, 2026 - in relation to the
Preferential issue of Equity shares and Fully Convertible warrants of Paramount Communications
Limited (“the Company”)
We write in our capacity of Monitoring Agency for the Preferential Issue for the amount aggregating to Rs.
122.63 crore (Preferential issue of equity share: Rs. 92.39 crore and Preferential issue of fully convertible share
warrants: Rs.30.24 crore) of the Company and refer to our duties cast under 162A of the Securities & Exchange
Board of India (Issue of Capital & Disclosure Requirements) Regulations.
In this connection, we are enclosing the Monitoring Agency Report for the quarter ended September 30, 2026,
as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated May 18, 2026.
Request you to kindly take the same on records.
Thanking you,
Yours faithfully,
Sandeep Aggarwal
Associate Director
Sandeep.aggarwal@careedge.in
CARE Ratings Limited
Plot no. C-001 A/2 Sector 16B, Berger Tower, Noida, Gautam 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off
Budh Nagar (UP) - 201301 Phone: +91-120-4452 000 Eastern Express Highway, Sion (East), Mumbai - 400 022
Phone: +91-22-6754 3456
Email: care@careedge.in • www.careedge.in
CIN-L67190MH1993PLC071691
Report of the Monitoring Agency
Name of the issuer: Paramount Communications Limited
For quarter ended: September 30, 2026
Name of the Monitoring Agency: CARE Ratings Limited
(a) Deviation from the objects: No
(b) Range of Deviation: Not Applicable
Declaration:
We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of
the issue based on the information provided by the Issuer and information obtained from sources believed by it to be
accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/
certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which
accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions
expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever.
Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA
and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as
defined under Section 2(38) of the Companies Act, 2013.
The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains
and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no
conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the
issuer, or while undertaking credit rating or other commercial transactions with the entity.
We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where
applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be
captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their
report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed
by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board.
Signature:
Name and designation of the Authorized Signatory: Sandeep Aggarwal
Designation of Authorized person/Signing Authority: Associate Director
CARE Ratings Limited
Plot no. C-001 A/2 Sector 16B, Berger Tower, Noida, Gautam 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off
Budh Nagar (UP) - 201301 Phone: +91-120-4452 000 Eastern Express Highway, Sion (East), Mumbai - 400 022
Phone: +91-22-6754 3456
Email: care@careedge.in • www.careedge.in
CIN-L67190MH1993PLC071691
1) Issue Details:
Name of the issuer : Paramount Communications Limited
Name of the promoter : Sanjay Aggarwal and Sandeep Aggarwal
Industry/sector to which it belongs : Cables - Electricals
2) Issue Details
Issue Period (Equity shares) : May 13, 2026, to July 01, 2026
Issue Period (Share warrants) : 18 months from the date of allotment (Date of allotment: July 01, 2026)
Type of issue (public/rights) : Preferential Issue
Type of specified securities : Equity shares and fully convertible warrants
IPO Grading, if any : Not applicable
Issue size of equity shares (in crore) : Rs. 92.39 crore
Issue size of share warrants (in crore) : Rs. 30.24 crore
CARE Ratings Limited
Plot no. C-001 A/2 Sector 16B, Berger Tower, Noida, Gautam 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off
Budh Nagar (UP) - 201301 Phone: +91-120-4452 000 Eastern Express Highway, Sion (East), Mumbai - 400 022
Phone: +91-22-6754 3456
Email: care@careedge.in • www.careedge.in
CIN-L67190MH1993PLC071691
3) Details of the arrangement made to ensure the monitoring of issue proceeds:
Source of information
/ certifications
Comments of the Comments of the
Particulars Reply considered by
Monitoring Agency Board of Directors
Monitoring Agency for
preparation of report
Vide Members resolution dated June
During Q2FY27, the company has utilized Rs. 73.39 06, 2026 the term “Board” includes any
crore as per the objectives mentioned in the private committee(s), which the Board has
placement offer. constituted or may constitute to
exercise its powers, including the
^During Q2FY27, the Company utilised Rs.9.00 crore powers conferred on the board by this
towards General Corporate Purposes (GCP) for resolution i.e., special resolution dated
operational expenses, including Customs House Agent June 06, 2026.
(CHA) services and bank charges. As per the offer In view of above, the banking Finance
document, the manner and proportion of utilisation of Committee of the Board has passed
CA certificate*,
Whether all utilization is as per the funds under GCP require Board approval. In support of the resolution dated July 01, 2026, for
Yes^ Management certificate,
disclosures in the Offer Document? the utilization under GCP during Q2FY27, the Company utilization of proceeds under general
[Showing first 8,000 characters — download PDF for full document]